<!DOCTYPE html>
<html lang="ko-KR">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="profile" href="http://gmpg.org/xfn/11">
    <link rel="pingback" href="http://da.nala.ga/xmlrpc.php">

<title>[종목] 휴젤에 대해서 살펴보겠습니다. | All About CC</title>

<!-- All in One SEO Pack 2.4.3.1 by Michael Torbert of Semper Fi Web Design[276,325] -->
<link rel="canonical" href="http://da.nala.ga/%ec%a2%85%eb%aa%a9-%ed%9c%b4%ec%a0%a4%ec%97%90-%eb%8c%80%ed%95%b4%ec%84%9c-%ec%82%b4%ed%8e%b4%eb%b3%b4%ea%b2%a0%ec%8a%b5%eb%8b%88%eb%8b%a4/" />
<!-- /all in one seo pack -->
<link rel='dns-prefetch' href='//s.w.org' />
<link rel="alternate" type="application/rss+xml" title="All About CC &raquo; 피드" href="http://da.nala.ga/feed/" />
<link rel="alternate" type="application/rss+xml" title="All About CC &raquo; 댓글 피드" href="http://da.nala.ga/comments/feed/" />
<link rel="alternate" type="application/rss+xml" title="All About CC &raquo; [종목] 휴젤에 대해서 살펴보겠습니다. 댓글 피드" href="http://da.nala.ga/%ec%a2%85%eb%aa%a9-%ed%9c%b4%ec%a0%a4%ec%97%90-%eb%8c%80%ed%95%b4%ec%84%9c-%ec%82%b4%ed%8e%b4%eb%b3%b4%ea%b2%a0%ec%8a%b5%eb%8b%88%eb%8b%a4/feed/" />
		<script type="text/javascript">
			window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/2.3\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/2.3\/svg\/","svgExt":".svg","source":{"concatemoji":"http:\/\/da.nala.ga\/wp-includes\/js\/wp-emoji-release.min.js?ver=4.8.4"}};
			!function(a,b,c){function d(a){var b,c,d,e,f=String.fromCharCode;if(!k||!k.fillText)return!1;switch(k.clearRect(0,0,j.width,j.height),k.textBaseline="top",k.font="600 32px Arial",a){case"flag":return k.fillText(f(55356,56826,55356,56819),0,0),b=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,56826,8203,55356,56819),0,0),c=j.toDataURL(),b!==c&&(k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57332,56128,56423,56128,56418,56128,56421,56128,56430,56128,56423,56128,56447),0,0),b=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57332,8203,56128,56423,8203,56128,56418,8203,56128,56421,8203,56128,56430,8203,56128,56423,8203,56128,56447),0,0),c=j.toDataURL(),b!==c);case"emoji4":return k.fillText(f(55358,56794,8205,9794,65039),0,0),d=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55358,56794,8203,9794,65039),0,0),e=j.toDataURL(),d!==e}return!1}function e(a){var c=b.createElement("script");c.src=a,c.defer=c.type="text/javascript",b.getElementsByTagName("head")[0].appendChild(c)}var f,g,h,i,j=b.createElement("canvas"),k=j.getContext&&j.getContext("2d");for(i=Array("flag","emoji4"),c.supports={everything:!0,everythingExceptFlag:!0},h=0;h<i.length;h++)c.supports[i[h]]=d(i[h]),c.supports.everything=c.supports.everything&&c.supports[i[h]],"flag"!==i[h]&&(c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&c.supports[i[h]]);c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&!c.supports.flag,c.DOMReady=!1,c.readyCallback=function(){c.DOMReady=!0},c.supports.everything||(g=function(){c.readyCallback()},b.addEventListener?(b.addEventListener("DOMContentLoaded",g,!1),a.addEventListener("load",g,!1)):(a.attachEvent("onload",g),b.attachEvent("onreadystatechange",function(){"complete"===b.readyState&&c.readyCallback()})),f=c.source||{},f.concatemoji?e(f.concatemoji):f.wpemoji&&f.twemoji&&(e(f.twemoji),e(f.wpemoji)))}(window,document,window._wpemojiSettings);
		</script>
		<style type="text/css">
img.wp-smiley,
img.emoji {
	display: inline !important;
	border: none !important;
	box-shadow: none !important;
	height: 1em !important;
	width: 1em !important;
	margin: 0 .07em !important;
	vertical-align: -0.1em !important;
	background: none !important;
	padding: 0 !important;
}
</style>
<link rel='stylesheet' id='bootstrap-css-css'  href='http://da.nala.ga/wp-content/themes/shaped-blog/assets/css/bootstrap.min.css?ver=3.3.5' type='text/css' media='all' />
<link rel='stylesheet' id='font-awesome-css-css'  href='http://da.nala.ga/wp-content/themes/shaped-blog/assets/css/font-awesome.min.css?ver=4.4.0' type='text/css' media='all' />
<link rel='stylesheet' id='shaped-blog-stylesheet-css'  href='http://da.nala.ga/wp-content/themes/shaped-blog/style.css?ver=4.8.4' type='text/css' media='all' />
<link rel='stylesheet' id='responsive-css-css'  href='http://da.nala.ga/wp-content/themes/shaped-blog/assets/css/responsive.css' type='text/css' media='all' />
<script type='text/javascript' src='http://da.nala.ga/wp-includes/js/jquery/jquery.js?ver=1.12.4'></script>
<script type='text/javascript' src='http://da.nala.ga/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1'></script>
<link rel='https://api.w.org/' href='http://da.nala.ga/wp-json/' />
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="http://da.nala.ga/xmlrpc.php?rsd" />
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="http://da.nala.ga/wp-includes/wlwmanifest.xml" /> 
<link rel='prev' title='정부 지원사업 독이냐?! 약이냐?!' href='http://da.nala.ga/%ec%a0%95%eb%b6%80-%ec%a7%80%ec%9b%90%ec%82%ac%ec%97%85-%eb%8f%85%ec%9d%b4%eb%83%90-%ec%95%bd%ec%9d%b4%eb%83%90/' />
<link rel='next' title='프랜차이즈 M&#038;A 매칭데이 행사' href='http://da.nala.ga/%ed%94%84%eb%9e%9c%ec%b0%a8%ec%9d%b4%ec%a6%88-ma-%eb%a7%a4%ec%b9%ad%eb%8d%b0%ec%9d%b4-%ed%96%89%ec%82%ac/' />
<meta name="generator" content="WordPress 4.8.4" />
<link rel='shortlink' href='http://da.nala.ga/?p=7220' />
<link rel="alternate" type="application/json+oembed" href="http://da.nala.ga/wp-json/oembed/1.0/embed?url=http%3A%2F%2Fda.nala.ga%2F%25ec%25a2%2585%25eb%25aa%25a9-%25ed%259c%25b4%25ec%25a0%25a4%25ec%2597%2590-%25eb%258c%2580%25ed%2595%25b4%25ec%2584%259c-%25ec%2582%25b4%25ed%258e%25b4%25eb%25b3%25b4%25ea%25b2%25a0%25ec%258a%25b5%25eb%258b%2588%25eb%258b%25a4%2F" />
<link rel="alternate" type="text/xml+oembed" href="http://da.nala.ga/wp-json/oembed/1.0/embed?url=http%3A%2F%2Fda.nala.ga%2F%25ec%25a2%2585%25eb%25aa%25a9-%25ed%259c%25b4%25ec%25a0%25a4%25ec%2597%2590-%25eb%258c%2580%25ed%2595%25b4%25ec%2584%259c-%25ec%2582%25b4%25ed%258e%25b4%25eb%25b3%25b4%25ea%25b2%25a0%25ec%258a%25b5%25eb%258b%2588%25eb%258b%25a4%2F&#038;format=xml" />

	<style>

		/* Border Color */
		.btn-social:hover,
		blockquote,
		#respond input:focus[type="text"], 
	    #respond input:focus[type="email"], 
	    #respond input:focus[type="url"],
	    #respond textarea:focus,
	    #comments .comment-reply a:hover
		{
			border-color: ;
		}

		
		/* Background Color */
		.scroll-up a,
		.btn-social:hover,
		button,
		input[type="button"],
		input[type="reset"],
		input[type="submit"],
		.navbar-default .navbar-nav .dropdown-menu li a:hover, .dropdown-menu li a:focus, .navbar-default .navbar-nav .dropdown-menu .active a,
		.pagination>li>a:focus, .pagination>li>a:hover, .pagination>li>span:focus, .pagination>li>span:hover, .pagination li .current,
		.next-previous-posts .next-post a:hover,
		.next-previous-posts .previous-post a:hover,
		.btn-goback,
		.btn-submit,
		a.more-link,
		.featured-post .fa,
		#comments .comment-reply a:hover,
		.widget .tagcloud a
		{
			background-color: ;
		}

		
		/* Color */
		.text-logo a,
		.navbar-default .navbar-nav .active a, .navbar-default .navbar-nav .active a:hover, .navbar-default .navbar-nav .active a:focus,
		.navbar-default .navbar-nav li a:hover, .navbar-default .navbar-nav li a:focus,
		a:hover,
    	a:focus,
		.next-previous-posts .previous-post a,
		.next-previous-posts .next-post a,
		.pagination>li>a, .pagination>li>span,
		#comments .comment-author a:hover, 
    	#respond .logged-in-as a:hover,
    	#wp-calendar a,
    	h2.entry-title a:hover
		{
			color: ;
		}


		/* A Color */
		a{
			color: ;
		}

		/* a:hover Color */
		a:hover,
		a:focus,
		a:active,
		.widget a:hover,
		.post .post-content .entry-meta ul li a:hover
		{
			color: ;
		}

		/* .featured-post .fa:after*/
		.featured-post .fa:after{
			border-color:   transparent ;
		}


		

	</style>
</head>

<body class="post-template-default single single-post postid-7220 single-format-standard">

    <div id="st-preloader">
        <div id="pre-status">
            <div class="preload-placeholder"></div>
        </div>
    </div>
<!-- /Preloader -->

<header id="header">	
	<div id="trueHeader">
    	<div class="wrapper">
            <div class="container">
            	<!-- Menu -->
            	<div class="menu_main">
                	<div class="navbar blogx-navbar navbar-default">
                        <div class="navbar-header">
                            <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#st-navber-collapse">
                                <span class="sr-only">Toggle navigation</span>
                                <span class="icon-bar"></span>
                                <span class="icon-bar"></span>
                                <span class="icon-bar"></span>
                            </button>

                                                            <div class="text-logo">
                                    <a href="http://da.nala.ga">All About CC</a>
                                    <p>All About CC Contents</p>
                                </div><!-- /Logo -->
                                                    </div>
                      
                        <div id="st-navber-collapse" class="navbar-collapse collapse pull-right">
                             
                        </div>
                    </div>
            	</div><!-- end menu -->
        	</div> <!-- /.container -->
    	</div>
	</div>
	<DIV class='ads_adsense_img' style='margin:40px 0px 40px 0px;'>
	<script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
	<!-- only display -->
	<ins class="adsbygoogle"
	     style="display:block"
	     data-ad-client="ca-pub-8393857339019314"
	     data-ad-slot="7474886381"
	     data-ad-format="auto"></ins>
	<script>
	(adsbygoogle = window.adsbygoogle || []).push({});
	</script>
	</DIV>	
</header>
    <div class="container">
        <div class="row">
            <div class="col-md-8">
                <div id="primary" class="content-area">
                    <main id="main" class="site-main" role="main">

                        
                                <article id="post-7220" class="post-7220 post type-post status-publish format-standard hentry category-uncategorized tag-1629 tag-11304 tag-9127 tag-11481">
    <header class="entry-header">
        
        
    </header> <!--/.entry-header -->

    <div class="clearfix post-content media">

        <h2 class="entry-title">
            [종목] 휴젤에 대해서 살펴보겠습니다.        </h2> <!-- //.entry-title -->

        <div class="clearfix entry-meta">
            
            <ul class="list-inline">
                <li>
                    <span class="author vcard">
                        By <a class="url fn n" href="http://da.nala.ga/author/site-admin/">site-admin</a>                    </span>
                </li>
                <li>
                    on <span class="posted-on">1월 10, 2018</span>
                </li>
                                    <li>
                        in <span class="posted-in">
                            <a href="http://da.nala.ga/category/uncategorized/" rel="category tag">미분류</a>                        </span>
                    </li>
                            </ul>
                </div> <!--/.entry-meta -->
        
        <div class="entry-summary">
            <h1>3줄 요약 </h1>
<div style='color:#fff;background-color:#000;border-radius:10px;'>
<ol>
<li><span>다. 회사의 핵심경쟁력</span></li>
<li><span>또한, 많은 국가들이 바이오 테러를 회피하기 위하여 보툴리눔 균주의 수입 <small>&#8230;중략&#8230;</small> 국내외적으로 보툴리눔 생산 균주나 원료를 입수하는 것 자체가 어렵습니다.</span></li>
<li><span>업계에서는 전 세계 신경 치료 관련 기기 시장은 2012년 12.5억달러 <small>&#8230;중략&#8230;</small>  약 95% 이상의 시장점유율을 차지하고 있는 것으로 추정하고 있습니다.</span></li>
</ol>
</div>
<p><span id="more-7220"></span></p>
<p><iframe src='http://ad.selfhow.com/rd' width='100%' border=0 frameborder=0 style='height:auto;width:100%'></iframe></p>
<hr /><!--StartFragment--></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">가</span><span style="FONT-SIZE: 12pt; FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">영업개황 및 공시대상 사업부문의 구분</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(1) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">보툴렉스 </span><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8211; </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">보툴리눔 톡신</span><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(botulinum toxin) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">제품</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">현재 당사의 해당 제품의 주요 사용 용도를 성형</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">미용을 위한 미간주름 외 눈꺼풀경련</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">뇌졸중 후 상지 근육 경직 및 소아 뇌성마비 후 첨족기형으로 확대하여 치료 시장에 진출하였습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">제품 사용의 편의성</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">경제성 증대 등을 목적으로 당사는 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">4</span><span style="mso-fareast-font-family: 고딕">개 제형 제품군을 보유하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">보툴리눔 독소는 강한 독성을 가진 단백질로</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">제조 시 나노그램 단위로 정확한 무게로 병마다 일정하게 주입되어야 안전한 제품이 될 수 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">당사의 제품은 엄격한 자체 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">QC(Quality Control)</span><span style="mso-fareast-font-family: 고딕">로 제형별 안정성 및 안정화된 역가를 유지하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">또한</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">희석 후 일정 시간 동안 냉장에서 안정적인 역가를 유지하여</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">사실상의 제품구매 결정자인 시술자</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(</span><span style="mso-fareast-font-family: 고딕">의사</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">)</span><span style="mso-fareast-font-family: 고딕">들의 사용 편의성이 높은 것이 특징입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(2) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">더채움 </span><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8211; HA</span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">필러</span><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Hyaluronic Acid filler)</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">더채움은 생체적합성 고분자로서 높은 안전성을 가진 히알루론산을 가교반응시켜 일정한 점탄성을 가진 겔</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(gel)</span><span style="mso-fareast-font-family: 고딕">을 제조하여 주사기에 충전한 제품으로 안면부에 주입하여 팔자주름 등의 주름개선 용도로 안면부에 사용되고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">특히 리도카인</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(lidocaine) </span><span style="mso-fareast-font-family: 고딕">성분을 첨가한 더채움 프리미엄은 시술 대상자의 통증을 현저히 완화시키고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">또한 주름 관리</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">안면 윤곽 등 다양한 목적별로 맞춤형 필러 제품군 출시를 통해 사용자 만족도를 높이고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p> </p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt">
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">나</span><span style="FONT-SIZE: 12pt; FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">시장 점유율</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">전 세계 시장 기준 미국 엘러간</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Allergan)</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;BOTOX&#8221;</span><span style="mso-fareast-font-family: 고딕">가 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">70% </span><span style="mso-fareast-font-family: 고딕">이상의 시장점유율을 확보하고있는 것으로 업계에서는 추정하고 있으며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">국내 시장에서는 동사의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">보툴렉스</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;, </span><span style="mso-fareast-font-family: 고딕">메디톡스</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">메디톡신</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">이 지배적 시장 점유율을 확보하고 있는 것으로 추정됩니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p> </p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt">
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">다</span><span style="FONT-SIZE: 12pt; FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">회사의 핵심경쟁력</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(1) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">진입 장벽</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">A. </span><span style="mso-fareast-font-family: 고딕">보툴리눔 톡신</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(botulinum toxin)</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">⒜ </span><span style="mso-fareast-font-family: 고딕">원료제조를 위한 균주 확보 측면</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">국내의 경우 보툴리눔 톡신</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(botulinum toxin)</span><span style="mso-fareast-font-family: 고딕">과 보툴리눔 균주</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Clostridium botulinum) </span><span style="mso-fareast-font-family: 고딕">모두 생물무기금지협약</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Biological Weapons Convention)</span><span style="mso-fareast-font-family: 고딕">의 대상물질이므로</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">제조신고</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">보유신고 및 수출입허가신고</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(</span><span style="mso-fareast-font-family: 고딕">한국바이오산업협회 및 지식경제부</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">)</span><span style="mso-fareast-font-family: 고딕">를 하여 국가기관의 허가를 받아야 합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">또한</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">세계적인 균주 기탁 및 배포 협회인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">ATCC(American Type Culture Collection)</span><span style="mso-fareast-font-family: 고딕">는 보툴리눔 균주의 분주</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(</span><span style="mso-fareast-font-family: 고딕">배포</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">)</span><span style="mso-fareast-font-family: 고딕">를 하지 않고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">또한</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">많은 국가들이 바이오 테러를 회피하기 위하여 보툴리눔 균주의 수입을 금지하거나 엄격한 절차를 거치고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">따라서 국내외적으로 보툴리눔 생산 균주나 원료를 입수하는 것 자체가 어렵습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">따라서 보툴리눔 독소 의약품이 바이오제네릭</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(biogeneric) </span><span style="mso-fareast-font-family: 고딕">제품으로 분류되어 이론적으로 누구나 시장진입이 가능하지만</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">제품생산을 위한 원료 확보 및 단백질의 분리</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">동정</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">독소의 정제 그리고 비임상 및 임상 시험을 포함한 안전성과 효능의 입증과정 등이 매우 어렵기 때문에 국내외적으로 이미 제조하고 있는 회사들의 장기간 과점을 가능하게 합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">⒝ </span><span style="mso-fareast-font-family: 고딕">정부의 규제 중 바이오 의약품의 허가 측면</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">식약처는 보툴리눔 독소 의약품을 자료제출 의약품으로 분류하지만</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">그 심사기준은 아주 높으며 생물학적제제인 바이오제네릭</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(biogeneric)</span><span style="mso-fareast-font-family: 고딕">의 허가 규정 수준을 통과할 수 있도록 지도를 하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">특히 보툴리눔 독소는 제조방법에 따라 역가 및 효능이 다르기 때문에 바이오 신약에 가까운 개발 과정을 거쳐야 합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">즉 생물학적제제에 대한 허가를 받으려면 동물을 대상으로 한 비임상시험자료와 함께 사람을 대상으로 한 임상시험자료를 제출하여야 합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">비임상시험은 비용이 많이 소요되며 특히</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">사람을 대상으로 한 임상시험에는 윤리적인 제약이 따를 뿐만 아니라 대규모 개발 비용이 소요되어 바이오벤처사가 감당하기 어려울 수 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">한편 바이오 의약품 산업은 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">GMP </span><span style="mso-fareast-font-family: 고딕">생산시설에 대한 투자가 필요하고 개발과정에 막대한 비용과 시간이 소요되기 때문에 진입장벽이 아주 높은 산업이라고 할 수 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">⒞ </span><span style="mso-fareast-font-family: 고딕">보툴리눔 독소 생물학적제제 제조 과정 측면</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">보툴리눔 독소는 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">1</span><span style="mso-fareast-font-family: 고딕">그램</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(1 gram)</span><span style="mso-fareast-font-family: 고딕">으로 백만 명을 사망시킬 수 있는 맹독이므로 제조 시 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">BL3(biosafety level 3) </span><span style="mso-fareast-font-family: 고딕">기준의 특수한 건물 및 장비를 추가로 설치해야 합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">이런 설비에 비용이 많이 들어갑니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">또한 이러한 맹독의 독소 단백질 제조 과정 중 필요한 기계설비 각각에 대한 설치검증 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">IQ(installation qualification) </span><span style="mso-fareast-font-family: 고딕">및 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">QC(quality control), QA(quality assurance) </span><span style="mso-fareast-font-family: 고딕">등 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">GMP </span><span style="mso-fareast-font-family: 고딕">충족 요구 사항이 많습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">동시에 보툴리눔 독소 의약품은 일 바이알</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(1 vial)</span><span style="mso-fareast-font-family: 고딕">에 일</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(1)~</span><span style="mso-fareast-font-family: 고딕">십</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(10) </span><span style="mso-fareast-font-family: 고딕">나노그램</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(nano gram)</span><span style="mso-fareast-font-family: 고딕">의 단백질을 주입하는 나노공정 수준으로 다년간의 경험 축적이 요구됩니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">B. </span><span style="mso-fareast-font-family: 고딕">필러</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(filler)</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">국내 필러 시장의 경우 상위 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">5</span><span style="mso-fareast-font-family: 고딕">개</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">가 전체 시장의 약 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">70% </span><span style="mso-fareast-font-family: 고딕">이상을 점유하는 과점시장으로 추정됩니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">스위스 갈더마</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Galderma)</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">레스틸렌</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Restylane)”</span><span style="mso-fareast-font-family: 고딕">과 미국 엘러간</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Allergan)</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">쥬비덤</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Juvederm)&#8221;</span><span style="mso-fareast-font-family: 고딕">이 시장을 선도해 왔으며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">국내회사 제조품목으로 당사 종속회사의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">더채움</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8221; </span><span style="mso-fareast-font-family: 고딕">등 국내 제품들이 시장점유율을 확대해 나가고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">필러 시장 진입에는 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">HA</span><span style="mso-fareast-font-family: 고딕">의 가교</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(Cross-Linking)</span><span style="mso-fareast-font-family: 고딕">와 관련된 기술 및 특화된 선충전주사기</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(prefilled syringe)</span><span style="mso-fareast-font-family: 고딕">의 충전 생산 시설 등의 대규모 설비투자 소요가 진입장벽으로 존재합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">안전성 및 유효성을 입증하기 위한 동물실험에서 인체에 적용하는 임상시험까지의 과정에 걸쳐 많은 비용과 시간 또한 진입장벽으로 작용합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">단</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">의료기기로 분류되는 제품의 특성상 보툴리눔 톡신제제에 비해 개발 난이도가 낮으며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">시장의 성장과 함께 신규 업체</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">제품의 진입 또한 지속 발생하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p> </p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt">
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(2) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">비교우위 사항</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">세계 수준의 보툴리눔 톡신</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">필러 제품 구성</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(portfolio)</span><span style="mso-fareast-font-family: 고딕">은 각 부문별 경쟁회사 대비 우위요소 입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">하나의 기업이 보툴리눔 톡신과 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">HA </span><span style="mso-fareast-font-family: 고딕">필러 등을 모두 제공할 때</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">번들판매</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(product bundling)</span><span style="mso-fareast-font-family: 고딕">을 통한 시너지</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(synergy)</span><span style="mso-fareast-font-family: 고딕">가 극대화되기 때문입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">또한 보툴리눔 톡신 관련하여</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">당사의 주요 경쟁우위 사항은</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">1) </span><span style="mso-fareast-font-family: 고딕">제품 가성비 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(</span><span style="mso-fareast-font-family: 고딕">높은 품질 대비 경제적인 판매가격</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">)</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2) </span><span style="mso-fareast-font-family: 고딕">고단위 제형인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">150·200unit</span><span style="mso-fareast-font-family: 고딕">에 대한 허가 보유</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">3) 7</span><span style="mso-fareast-font-family: 고딕">년 이상의 임상 적용 경험 등에 기반한 제품 안전성 등으로 요약할 수 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p> </p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt">
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">라</span><span style="FONT-SIZE: 12pt; FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="FONT-SIZE: 12pt; FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">신규사업 등의 내용 및 전망</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(1) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">고기능성 화장품 부문</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">코스메슈티컬</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(cosmeceuticals)</span><span style="mso-fareast-font-family: 고딕">은 화장품</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(cosmetics)</span><span style="mso-fareast-font-family: 고딕">과 제약</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(pharmaceutical)</span><span style="mso-fareast-font-family: 고딕">의 합성어로</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">검증된 효능의 의약 성분을 이용해 만든 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8216;</span><span style="mso-fareast-font-family: 고딕">치료 화장품</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8216;</span><span style="mso-fareast-font-family: 고딕">을 뜻합니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">또한 의사</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">약사 등 의료전문가가 연구 개발에 참여한 전문 제품을 지칭하며 미백</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">주름에서 한걸음 더 나아가 피부 질환 치료를 돕는 제품으로 고부가 성장분야입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">전 세계 코스메슈티컬</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(cosmeceuticals) </span><span style="mso-fareast-font-family: 고딕">시장은 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2015</span><span style="mso-fareast-font-family: 고딕">년 기준 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">400</span><span style="mso-fareast-font-family: 고딕">억 달러</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(USD)</span><span style="mso-fareast-font-family: 고딕">로 연평균 약 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">15% </span><span style="mso-fareast-font-family: 고딕">이상 성장하여 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2017</span><span style="mso-fareast-font-family: 고딕">년에는 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">470</span><span style="mso-fareast-font-family: 고딕">억 달러</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(USD)</span><span style="mso-fareast-font-family: 고딕">에 이를 것으로 전망하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span><span style="mso-fareast-font-family: 고딕">국내 시장 또한 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2015</span><span style="mso-fareast-font-family: 고딕">년 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2,000</span><span style="mso-fareast-font-family: 고딕">억을 넘으면서 전년대비 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">40% </span><span style="mso-fareast-font-family: 고딕">급성장 하면서 신규 고성장 카테고리로 주목받고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">당사는 이러한 시장의 흐름에 주목하여 축적된 당사의 피부미용 전문 연구개발</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">판매 역량을 발휘할 수 있는 분야로 판단하여 사업에 집중하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">해당 사업군의 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">웰라쥬</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(WELLAGE)&#8221;</span><span style="mso-fareast-font-family: 고딕">는 휴젤 연구소와 미용성형 전문의들의 임상경험을 토대로 탄생된 고기능성</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">화장품 브랜드입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">피부 노화 증상으로부터의 피부 보호를 목적으로 하며 나아가 여드름</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">민감성</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">악건성 등 피부의 근본적인 문제를 치유하며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">피부를 건강하고 아름답게 가꾸어 주는 고기능성 화장품을 선보이고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">당사 제품군의 또 하나의 특징은 기본적으로 안전함을 바탕으로 한 제품이라는 것입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">피부 유해 성분은 최대한 배제 또는 최소 성분 사용으로 안전할 뿐만 아니라</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">전 제품은 출시 전 피부과 자극 테스트 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(skin irritation test)</span><span style="mso-fareast-font-family: 고딕">를 거쳐 완성됩니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">아울러 효능</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">효과 측면에서도 진피치밀도 개선</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">멜라닌 감소</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">피부 장벽강화 등 제품 사용 목적에 맞게 전문 피부 임상 연구센터와 협력하여 인체 임상을 하고 객관적인 데이터를 구축하였으며 이를 통하여 웰라쥬의 제품은 그 효과 및 안전성을 인정 받고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2017</span><span style="mso-fareast-font-family: 고딕">년에는 작년에 이어 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">20, 30 </span><span style="mso-fareast-font-family: 고딕">세대를 위한 새로운 스킨케어 라인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">SMART HA®</span><span style="mso-fareast-font-family: 고딕">에서 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">11 </span><span style="mso-fareast-font-family: 고딕">여종의 제품 라인을 갖추면서</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">하반기에는 수분라인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">7</span><span style="mso-fareast-font-family: 고딕">종</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">모공라인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">6</span><span style="mso-fareast-font-family: 고딕">종 외 남성라인</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">베이스 색조라인 등 다양한 니즈에 맞는 신상품을 출시하여 더마시장에서의 경쟁력을 강화하고 전략적 마케팅 활동을 통해 코스메슈티컬</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(cosmeceuticals) </span><span style="mso-fareast-font-family: 고딕">화장품 시장에서의 성장을 기대하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">또한 해외 시장</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">그 중 특히 중국 및 미주 시장 진출 가시화를 바탕으로 기존의 보툴리눔 톡신</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">/</span><span style="mso-fareast-font-family: 고딕">필러 제품과 함께 당사의 주요 제품으로 자리매김할 것으로 전망하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(2) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">뇌질환 관련 중재술 사용 재료</span><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(coil, catheter </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">등</span><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">판매</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">당사는 종속회사인 휴젤메디텍</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">㈜</span><span style="mso-fareast-font-family: 고딕">을 통해</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">신경 중재 치료에 사용되는 각종 제품</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">기구</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(medical device) </span><span style="mso-fareast-font-family: 고딕">수입 판매 사업에 진출하였습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">휴젤메디텍</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">㈜</span><span style="mso-fareast-font-family: 고딕">은 미국 마이크로벤션</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(MicroVention)</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">의 뇌동맥류 코일링 기술로 개발된 제품 수입판매업을 영위하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">업계에서는 전 세계 신경 치료 관련 기기 시장은 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2012</span><span style="mso-fareast-font-family: 고딕">년 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">12.5</span><span style="mso-fareast-font-family: 고딕">억달러</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(USD)</span><span style="mso-fareast-font-family: 고딕">에서 연평균 약 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">6 ~ 8% </span><span style="mso-fareast-font-family: 고딕">성장율을 시현하며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, 2017</span><span style="mso-fareast-font-family: 고딕">년에는 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">17.3</span><span style="mso-fareast-font-family: 고딕">억달러 규모를 형성할 것으로 전망하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">해당 시장에서 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">Stryker, Medtronic, Johnson &amp; Johnson, MicroVention 4</span><span style="mso-fareast-font-family: 고딕">개 </span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">가 약 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">95% </span><span style="mso-fareast-font-family: 고딕">이상의 시장점유율을 차지하고 있는 것으로 추정하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">휴젤메디텍</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">㈜</span><span style="mso-fareast-font-family: 고딕">의 주요 제품 수입처인 마이크로벤션</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(MicroVention)</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 명조">社</span><span style="mso-fareast-font-family: 고딕">의 주력 기술은 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2</span><span style="mso-fareast-font-family: 고딕">세대 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">brain aneurysm </span><span style="mso-fareast-font-family: 고딕">치료 재료인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">coil product </span><span style="mso-fareast-font-family: 고딕">이며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">모회사인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">Terumo</span><span style="mso-fareast-font-family: 고딕">로부터 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">non-coil </span><span style="mso-fareast-font-family: 고딕">제품 기술을 이전 받아 차세대 기술로 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">non-coil </span><span style="mso-fareast-font-family: 고딕">재료에 대한 수요 증가에 대응한 제품을 생산하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. 2015</span><span style="mso-fareast-font-family: 고딕">년 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">3</span><span style="mso-fareast-font-family: 고딕">월 경쟁사 대비 제품력이 우수한 코일이탈방지용 스텐트 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">LVIS</span><span style="mso-fareast-font-family: 고딕">를 출시하고</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, 2017</span><span style="mso-fareast-font-family: 고딕">년 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">4</span><span style="mso-fareast-font-family: 고딕">월에는 뇌혈관내색전촉진용보철재 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">PHIL</span><span style="mso-fareast-font-family: 고딕">을 출시 예정하고 있는 등 생산 제품 경쟁력 증가와 함께 매출 또한 증대를 전망하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">또한 최근 가파른 성장 추이를 나타내고 있는 신경혈관중재 시장에서 지속적인 매출과 이익을 내고 있는 영업력</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">평판은 당사의 보툴렉스의 신경계질환 치료제 시장 진출</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(</span><span style="mso-fareast-font-family: 고딕">보툴렉스 치료용 적응증인 소아뇌성마비 및 뇌졸중 관련</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">)</span><span style="mso-fareast-font-family: 고딕">을 위한 종합병원 시장에서의 영향력 확대에도 유</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">·</span><span style="mso-fareast-font-family: 고딕">무형의 자원이 될 것으로 기대하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(3) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">무통 액상형 보툴리눔 톡신 제품 개발 및 제조</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">당사는 현재 동결건조 제형 중심 제품군의 안전성</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">보관 편리성 개선 등을 목적으로 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">&#8220;</span><span style="mso-fareast-font-family: 고딕">무통 액상형</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">”</span><span style="mso-fareast-font-family: 고딕">보툴리눔 톡신 제품 개발을 진행하고 있습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="FONT-FAMILY: 고딕; FONT-WEIGHT: bold; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(4) </span><span style="FONT-WEIGHT: bold; mso-fareast-font-family: 고딕">흉터치료제 신약</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">바이오 의약품 관련하여</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">미래 신약 개발의 핵심 기술로서 가장 주목 받고 있는 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">RNA</span><span style="mso-fareast-font-family: 고딕">간섭</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">(RNA interference; RNAi) </span><span style="mso-fareast-font-family: 고딕">기술을 바탕으로 다양한 질병에 대한 신약 개발을 진행 중입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">흉터의 예방 및 치료를 위한 핵산치료제의 경우</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">미국 글로벌 대기업에서도 관련 제품을 임상 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">2</span><span style="mso-fareast-font-family: 고딕">상 연구를 완성하여 약제화 가능성이 높음을 보여준 상태입니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span></p>
<p class="0" style="TEXT-AUTOSPACE: ; mso-pagination: none; mso-padding-alt: 0.0pt 0.0pt 0.0pt 0.0pt"><span style="mso-fareast-font-family: 고딕">첨단 기술인 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">RNAi </span><span style="mso-fareast-font-family: 고딕">기반의 치료제의 경우 전세계적으로 글로벌 기업 및 미국 바이오벤처 등에서 많은 연구가 이루어지고 있으며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">당사의 흉터치료제의 경우 기초실험과 동물실험을 통해 미국 글로벌 대기업과 동일한 메커니즘을 거치는 효과를 나타냈습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">. </span><span style="mso-fareast-font-family: 고딕">당사는 관련 특허 기술을 가진 올릭스</span><span style="LETTER-SPACING: 0pt; mso-font-width: 100%; mso-text-raise: 0.0pt; mso-fareast-font-family: 고딕; mso-hansi-font-family: 명조">㈜</span><span style="mso-fareast-font-family: 고딕">에서 기술이전계약을 맺고 기술을 도입하였으며</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">, </span><span style="mso-fareast-font-family: 고딕">아시아 시장의 판권을 보유하고 있으며 현재 범부처전주기사업 과제로 선정되어 비임상 실험을 완료하였고 임상</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">1</span><span style="mso-fareast-font-family: 고딕">상 시험을 위한 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">IND </span><span style="mso-fareast-font-family: 고딕">허가를 받아 아산병원 </span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">IRB</span><span style="mso-fareast-font-family: 고딕">에 심의 신청하였습니다</span><span style="FONT-FAMILY: 고딕; LETTER-SPACING: 0pt; mso-ascii-font-family: 고딕; mso-font-width: 100%; mso-text-raise: 0.0pt">.</span></p>
<hr />
<p><iframe src='http://ad.selfhow.com/rd' width='100%' border=0 frameborder=0 style='height:auto;width:100%'></iframe></p>
<p><a href='http://yes-we-can.tistory.com/37' target='_blank'>Origin Content : 경제적 자유를 꿈꾸며</a> | <a href="/cdn-cgi/l/email-protection#6207010d3d0101525253220c030e034c0503" target='_blank'>Contact : <span class="__cf_email__" data-cfemail="096c6a66566a6a3939384967686568276e68">[email&#160;protected]</span></a>
</p>
<p>Cotent License : CC-BY </p>
<p>This content is collected under the CCL license.</p>
<p>Please check the license of the original article before asking about copyright.</p>
<ul>
<li><a href='/tag/종목'>More About <span style='font-weight:bold;'>종목</span></a></li>
<li><a href='/tag/휴젤에'>More About <span style='font-weight:bold;'>휴젤에</span></a></li>
<li><a href='/tag/대해서'>More About <span style='font-weight:bold;'>대해서</span></a></li>
<li><a href='/tag/살펴보겠습니다'>More About <span style='font-weight:bold;'>살펴보겠습니다</span></a></li>
</ul>
        </div> <!-- //.entry-summary -->
        
                    <div class="entry-tags"><b>Tags:</b> <a href="http://da.nala.ga/tag/%eb%8c%80%ed%95%b4%ec%84%9c/" rel="tag">대해서</a>, <a href="http://da.nala.ga/tag/%ec%82%b4%ed%8e%b4%eb%b3%b4%ea%b2%a0%ec%8a%b5%eb%8b%88%eb%8b%a4/" rel="tag">살펴보겠습니다</a>, <a href="http://da.nala.ga/tag/%ec%a2%85%eb%aa%a9/" rel="tag">종목</a>, <a href="http://da.nala.ga/tag/%ed%9c%b4%ec%a0%a4%ec%97%90/" rel="tag">휴젤에</a></div>
        
    </div>

</article> <!--/#post-->





                                                                    <div class="post-nav-area">
                                                    
            <nav class="next-previous-post clearfix media" role="navigation">
                <div class="row">
                    <!-- Previous Post -->
                    <div class="previous-post col-sm-6 pull-left">
                        <div class="nav-previous"><i class="fa fa-angle-left"></i> <a href="http://da.nala.ga/%ec%a0%95%eb%b6%80-%ec%a7%80%ec%9b%90%ec%82%ac%ec%97%85-%eb%8f%85%ec%9d%b4%eb%83%90-%ec%95%bd%ec%9d%b4%eb%83%90/" rel="prev">정부 지원사업 독이냐?! 약이냐?!</a></div>                    </div>

                    <!-- Next Post -->
                    <div class="next-post col-sm-6 pull-right text-right">
                        <div class="nav-next"><a href="http://da.nala.ga/%ed%94%84%eb%9e%9c%ec%b0%a8%ec%9d%b4%ec%a6%88-ma-%eb%a7%a4%ec%b9%ad%eb%8d%b0%ec%9d%b4-%ed%96%89%ec%82%ac/" rel="next">프랜차이즈 M&#038;A 매칭데이 행사</a> <i class="fa fa-angle-right"></i></div>                    </div>
                </div>
            </nav><!-- .navigation -->
            
                                            </div>
                                
                                
                            
                                            </main> <!-- /.site-main -->
                </div>  <!-- /.content-area -->
            </div> <!-- /col -->

            <!-- Blogsidebar -->
            
	<div class="col-md-4">
	    <div class="primary-sidebar widget-area" role="complementary">
	        <div id="search-2" class="widget widget_search"><form role="search" method="get" class="search-form" action="http://da.nala.ga/">
				<label>
					<span class="screen-reader-text">검색:</span>
					<input type="search" class="search-field" placeholder="검색 &hellip;" value="" name="s" />
				</label>
				<input type="submit" class="search-submit" value="검색" />
			</form></div>		<div id="recent-posts-2" class="widget widget_recent_entries">		<h2 class="widget-title">최근 글</h2>		<ul>
					<li>
				<a href="http://da.nala.ga/%ea%b5%90%ed%99%98%ed%95%99%ec%83%9d%ec%a4%80%eb%b9%84part2-%ed%94%84%eb%9e%91%ec%8a%a4-sciences-po-%ec%a7%80%ec%9b%90-%ea%b3%bc%ec%a0%95%ea%b3%bc-%ea%b7%b8-%ec%a0%84-%ec%95%8c%ec%95%84%ec%95%bc/">[교환학생준비PART2] 프랑스 Sciences Po 지원 과정과 그 전 알아야할 것들!</a>
						</li>
					<li>
				<a href="http://da.nala.ga/%eb%b0%95%ea%b7%bc%ed%98%9c-%ec%b5%9c%ec%88%9c%ec%8b%a4-%ea%b2%8c%ec%9d%b4%ed%8a%b8%eb%a5%bc-%eb%b0%9d%ed%98%80%eb%82%b8-%ec%9d%bc%eb%93%b1%ea%b3%b5%ec%8b%a0-%ec%95%88%eb%af%bc%ec%84%9d/">박근혜 최순실 게이트를 밝혀낸 일등공신 안민석</a>
						</li>
					<li>
				<a href="http://da.nala.ga/%eb%b0%b0%ed%8b%80%ea%b7%b8%eb%9d%bc%ec%9a%b4%eb%93%9c-%ec%a0%95%ec%8b%9d%eb%b2%84%ec%a0%84-1-0%ed%8c%a8%ec%b9%98-%eb%ac%b4%ec%97%87%ec%9d%b4-%eb%b0%94%eb%80%8c%eb%82%98%ec%9a%94/">배틀그라운드 정식버전 1.0패치 무엇이 바뀌나요?</a>
						</li>
					<li>
				<a href="http://da.nala.ga/%eb%91%90%eb%87%8c%eb%a5%bc-%ea%b1%b4%ea%b0%95%ed%95%98%ea%b2%8c-%eb%a7%8c%eb%93%9c%eb%8a%94-4%ec%b2%9c%eb%b3%b4%ec%9d%98-%ea%b1%b8%ec%9d%8c/">두뇌를 건강하게 만드는 4천보의 걸음</a>
						</li>
					<li>
				<a href="http://da.nala.ga/%eb%af%b8%ea%b5%ad-%ec%9c%a0%ed%95%99-%ec%a0%95%eb%b3%b4-%ed%95%9c%ea%b5%ad-%eb%82%b4%ec%8b%a0-%ec%84%b1%ec%a0%81%eb%a7%8c%ec%9c%bc%eb%a1%9c-%eb%af%b8%ea%b5%ad-%eb%aa%85%eb%ac%b8%eb%8c%80-%ea%b0%80/">미국 유학  정보 &#8211; 한국 내신 성적만으로 미국 명문대 가기</a>
						</li>
				</ul>
		</div>		<div id="tag_cloud-2" class="widget widget_tag_cloud"><h2 class="widget-title">태그</h2><div class="tagcloud"><a href="http://da.nala.ga/tag/1%ec%9b%94/" class="tag-cloud-link tag-link-35 tag-link-position-1" style="font-size: 14.892307692308pt;" aria-label="1월 (47 아이템)">1월</a>
<a href="http://da.nala.ga/tag/2017/" class="tag-cloud-link tag-link-510 tag-link-position-2" style="font-size: 19.415384615385pt;" aria-label="2017 (76 아이템)">2017</a>
<a href="http://da.nala.ga/tag/2017%eb%85%84/" class="tag-cloud-link tag-link-8 tag-link-position-3" style="font-size: 18.123076923077pt;" aria-label="2017년 (66 아이템)">2017년</a>
<a href="http://da.nala.ga/tag/2018/" class="tag-cloud-link tag-link-61 tag-link-position-4" style="font-size: 14.461538461538pt;" aria-label="2018 (45 아이템)">2018</a>
<a href="http://da.nala.ga/tag/2018%eb%85%84/" class="tag-cloud-link tag-link-103 tag-link-position-5" style="font-size: 18.984615384615pt;" aria-label="2018년 (73 아이템)">2018년</a>
<a href="http://da.nala.ga/tag/vs/" class="tag-cloud-link tag-link-943 tag-link-position-6" style="font-size: 9.5076923076923pt;" aria-label="vs (26 아이템)">vs</a>
<a href="http://da.nala.ga/tag/%ec%98%81%ed%99%94/" class="tag-cloud-link tag-link-1375 tag-link-position-7" style="font-size: 14.246153846154pt;" aria-label="“영화 (44 아이템)">“영화</a>
<a href="http://da.nala.ga/tag/%ea%b0%80%ea%b2%a9/" class="tag-cloud-link tag-link-63 tag-link-position-8" style="font-size: 12.953846153846pt;" aria-label="가격 (38 아이템)">가격</a>
<a href="http://da.nala.ga/tag/%ea%b0%80%ec%83%81%ed%99%94%ed%8f%90/" class="tag-cloud-link tag-link-1479 tag-link-position-9" style="font-size: 9.0769230769231pt;" aria-label="가상화폐 (25 아이템)">가상화폐</a>
<a href="http://da.nala.ga/tag/%ea%b2%80%ec%9d%80%ec%82%ac%eb%a7%89/" class="tag-cloud-link tag-link-341 tag-link-position-10" style="font-size: 8.8615384615385pt;" aria-label="검은사막 (24 아이템)">검은사막</a>
<a href="http://da.nala.ga/tag/%ea%b2%8c%ec%9e%84/" class="tag-cloud-link tag-link-391 tag-link-position-11" style="font-size: 22pt;" aria-label="게임 (102 아이템)">게임</a>
<a href="http://da.nala.ga/tag/%ea%b3%b5%ea%b0%9c/" class="tag-cloud-link tag-link-938 tag-link-position-12" style="font-size: 9.5076923076923pt;" aria-label="공개 (26 아이템)">공개</a>
<a href="http://da.nala.ga/tag/%ea%b3%b5%eb%9e%b5/" class="tag-cloud-link tag-link-1018 tag-link-position-13" style="font-size: 8.8615384615385pt;" aria-label="공략 (24 아이템)">공략</a>
<a href="http://da.nala.ga/tag/%eb%8b%a4%ec%9a%b4%eb%a1%9c%eb%93%9c/" class="tag-cloud-link tag-link-364 tag-link-position-14" style="font-size: 8.4307692307692pt;" aria-label="다운로드 (23 아이템)">다운로드</a>
<a href="http://da.nala.ga/tag/%eb%8c%80%ed%95%b4%ec%84%9c/" class="tag-cloud-link tag-link-1629 tag-link-position-15" style="font-size: 8.8615384615385pt;" aria-label="대해서 (24 아이템)">대해서</a>
<a href="http://da.nala.ga/tag/%eb%a6%ac%eb%b7%b0/" class="tag-cloud-link tag-link-555 tag-link-position-16" style="font-size: 15.969230769231pt;" aria-label="리뷰 (53 아이템)">리뷰</a>
<a href="http://da.nala.ga/tag/%eb%a7%9b%ec%a7%91/" class="tag-cloud-link tag-link-4173 tag-link-position-17" style="font-size: 9.9384615384615pt;" aria-label="맛집 (27 아이템)">맛집</a>
<a href="http://da.nala.ga/tag/%eb%aa%a8%eb%b0%94%ec%9d%bc/" class="tag-cloud-link tag-link-835 tag-link-position-18" style="font-size: 10.584615384615pt;" aria-label="모바일 (29 아이템)">모바일</a>
<a href="http://da.nala.ga/tag/%eb%ac%b4%eb%a3%8c/" class="tag-cloud-link tag-link-827 tag-link-position-19" style="font-size: 13.384615384615pt;" aria-label="무료 (40 아이템)">무료</a>
<a href="http://da.nala.ga/tag/%eb%b0%a9%eb%b2%95/" class="tag-cloud-link tag-link-529 tag-link-position-20" style="font-size: 15.323076923077pt;" aria-label="방법 (49 아이템)">방법</a>
<a href="http://da.nala.ga/tag/%eb%b9%84%ed%8a%b8%ec%bd%94%ec%9d%b8/" class="tag-cloud-link tag-link-1478 tag-link-position-21" style="font-size: 9.0769230769231pt;" aria-label="비트코인 (25 아이템)">비트코인</a>
<a href="http://da.nala.ga/tag/%ec%84%a4%ec%b9%98/" class="tag-cloud-link tag-link-360 tag-link-position-22" style="font-size: 8pt;" aria-label="설치 (22 아이템)">설치</a>
<a href="http://da.nala.ga/tag/%ec%86%8c%ea%b0%9c/" class="tag-cloud-link tag-link-297 tag-link-position-23" style="font-size: 8.4307692307692pt;" aria-label="소개 (23 아이템)">소개</a>
<a href="http://da.nala.ga/tag/%ec%88%9c%ec%9c%84/" class="tag-cloud-link tag-link-12 tag-link-position-24" style="font-size: 11.230769230769pt;" aria-label="순위 (31 아이템)">순위</a>
<a href="http://da.nala.ga/tag/%ec%8b%9c%ec%9e%91/" class="tag-cloud-link tag-link-579 tag-link-position-25" style="font-size: 8.4307692307692pt;" aria-label="시작 (23 아이템)">시작</a>
<a href="http://da.nala.ga/tag/%ec%95%88%eb%82%b4/" class="tag-cloud-link tag-link-338 tag-link-position-26" style="font-size: 10.584615384615pt;" aria-label="안내 (29 아이템)">안내</a>
<a href="http://da.nala.ga/tag/%ec%95%8c%ec%95%84%eb%b3%b4%ea%b8%b0/" class="tag-cloud-link tag-link-1939 tag-link-position-27" style="font-size: 12.523076923077pt;" aria-label="알아보기 (36 아이템)">알아보기</a>
<a href="http://da.nala.ga/tag/%ec%95%8c%ec%95%84%eb%b3%b4%ec%9e%90/" class="tag-cloud-link tag-link-369 tag-link-position-28" style="font-size: 11.661538461538pt;" aria-label="알아보자 (33 아이템)">알아보자</a>
<a href="http://da.nala.ga/tag/%ec%97%85%eb%8d%b0%ec%9d%b4%ed%8a%b8/" class="tag-cloud-link tag-link-567 tag-link-position-29" style="font-size: 9.0769230769231pt;" aria-label="업데이트 (25 아이템)">업데이트</a>
<a href="http://da.nala.ga/tag/%ec%97%ac%ed%96%89/" class="tag-cloud-link tag-link-1122 tag-link-position-30" style="font-size: 12.738461538462pt;" aria-label="여행 (37 아이템)">여행</a>
<a href="http://da.nala.ga/tag/%ec%98%a4%eb%b8%8c/" class="tag-cloud-link tag-link-271 tag-link-position-31" style="font-size: 10.8pt;" aria-label="오브 (30 아이템)">오브</a>
<a href="http://da.nala.ga/tag/%ec%98%a8%eb%9d%bc%ec%9d%b8/" class="tag-cloud-link tag-link-328 tag-link-position-32" style="font-size: 11.876923076923pt;" aria-label="온라인 (34 아이템)">온라인</a>
<a href="http://da.nala.ga/tag/%ec%9c%84%ed%95%9c/" class="tag-cloud-link tag-link-183 tag-link-position-33" style="font-size: 13.169230769231pt;" aria-label="위한 (39 아이템)">위한</a>
<a href="http://da.nala.ga/tag/%ec%9d%b4%eb%b2%a4%ed%8a%b8/" class="tag-cloud-link tag-link-723 tag-link-position-34" style="font-size: 13.169230769231pt;" aria-label="이벤트 (39 아이템)">이벤트</a>
<a href="http://da.nala.ga/tag/%ec%9d%b4%ec%95%bc%ea%b8%b0/" class="tag-cloud-link tag-link-861 tag-link-position-35" style="font-size: 10.8pt;" aria-label="이야기 (30 아이템)">이야기</a>
<a href="http://da.nala.ga/tag/%ec%9d%b4%ec%9c%a0/" class="tag-cloud-link tag-link-1482 tag-link-position-36" style="font-size: 9.9384615384615pt;" aria-label="이유 (27 아이템)">이유</a>
<a href="http://da.nala.ga/tag/%ec%9d%bc%eb%b3%b8/" class="tag-cloud-link tag-link-1007 tag-link-position-37" style="font-size: 8.4307692307692pt;" aria-label="일본 (23 아이템)">일본</a>
<a href="http://da.nala.ga/tag/%ec%a0%95%eb%a6%ac/" class="tag-cloud-link tag-link-65 tag-link-position-38" style="font-size: 11.876923076923pt;" aria-label="정리 (34 아이템)">정리</a>
<a href="http://da.nala.ga/tag/%ec%a0%95%eb%b3%b4/" class="tag-cloud-link tag-link-610 tag-link-position-39" style="font-size: 17.261538461538pt;" aria-label="정보 (61 아이템)">정보</a>
<a href="http://da.nala.ga/tag/%ec%b4%9d%ec%a0%95%eb%a6%ac/" class="tag-cloud-link tag-link-179 tag-link-position-40" style="font-size: 8.4307692307692pt;" aria-label="총정리 (23 아이템)">총정리</a>
<a href="http://da.nala.ga/tag/%ec%b5%9c%ea%b3%a0/" class="tag-cloud-link tag-link-404 tag-link-position-41" style="font-size: 11.876923076923pt;" aria-label="최고 (34 아이템)">최고</a>
<a href="http://da.nala.ga/tag/%ec%b6%94%ec%b2%9c/" class="tag-cloud-link tag-link-367 tag-link-position-42" style="font-size: 20.707692307692pt;" aria-label="추천 (89 아이템)">추천</a>
<a href="http://da.nala.ga/tag/%ec%b6%9c%ec%8b%9c/" class="tag-cloud-link tag-link-612 tag-link-position-43" style="font-size: 10.584615384615pt;" aria-label="출시 (29 아이템)">출시</a>
<a href="http://da.nala.ga/tag/%ed%95%9c%ea%b5%ad/" class="tag-cloud-link tag-link-1483 tag-link-position-44" style="font-size: 10.153846153846pt;" aria-label="한국 (28 아이템)">한국</a>
<a href="http://da.nala.ga/tag/%ed%9b%84%ea%b8%b0/" class="tag-cloud-link tag-link-114 tag-link-position-45" style="font-size: 19.2pt;" aria-label="후기 (74 아이템)">후기</a></div>
</div>	    </div>
	</div>

        </div> <!-- /.row -->
    </div> <!-- /.container -->
    <div class="container">
        <div class="row">
            <div class="col-md-12">
                <hr>
            </div>
        </div>
    </div>
    <footer class="site-footer" role="contentinfo">
        <div class="container">
            <div class="row">
                <div class="col-sm-12 text-center">
  
                    <p></p>
                    
                                            <div class="footer-social-icons">
                                                                                                                                                                                                                                                                                                                                                                                                        
                        </div>
                    
                </div>
            </div>
        </div>
    </footer>

            <div class="scroll-up">
            <a href="#"><i class="fa fa-angle-up"></i></a>
        </div>
        <!-- Scroll Up -->

    <script data-cfasync="false" src="/cdn-cgi/scripts/af2821b0/cloudflare-static/email-decode.min.js"></script><script type='text/javascript' src='http://da.nala.ga/wp-content/themes/shaped-blog/assets/js/bootstrap.min.js?ver=3.3.5'></script>
<script type='text/javascript' src='http://da.nala.ga/wp-content/themes/shaped-blog/assets/js/scripts.js'></script>
<script type='text/javascript' src='http://da.nala.ga/wp-content/themes/shaped-blog/assets/js/jquery.fitvids.js'></script>
<script type='text/javascript' src='http://da.nala.ga/wp-content/themes/shaped-blog/assets/js/smoothscroll.js'></script>
<script type='text/javascript' src='http://da.nala.ga/wp-includes/js/wp-embed.min.js?ver=4.8.4'></script>
    </body>
</html>